price
MN
NASDAQ · MNKD
MannKind Corporation
Healthcare · Biotechnology
$4.40
Down-$0.12 (-2.62%)
Updated Aug 20, 2026, 1:59 PM
SID Score
5.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.78B
- P/E ratio
- 53.97
- Dividend yield
- 0.00%
- 52-week range
- $2.23 – $4.55
- Volume
- 5.44M
- Avg. volume
- 3.97M
Price performance
MNKD price history
1M range · 21 trading sessions · Daily adjusted prices
MNKD closed at $4.40 after 21 trading sessions, up 14.45% for the selected period.
- Last close
- $4.40
- Period change
- +14.45%
- Period low
- $3.73
- Period high
- $4.40
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 19, 2026 | $4.10 | $4.40 | $4.10 | $4.395 | 5.44M |
| Aug 18, 2026 | $3.87 | $4.10 | $3.87 | $4.07 | 4.6M |
| Aug 17, 2026 | $3.85 | $3.94 | $3.804 | $3.90 | 3.32M |
| Aug 14, 2026 | $3.74 | $3.85 | $3.69 | $3.85 | 2.86M |
| Aug 13, 2026 | $3.88 | $3.895 | $3.63 | $3.73 | 5.24M |
| Aug 12, 2026 | $3.86 | $3.92 | $3.835 | $3.85 | 3.06M |
| Aug 11, 2026 | $3.91 | $3.98 | $3.815 | $3.84 | 4.5M |
| Aug 10, 2026 | $4.065 | $4.08 | $3.88 | $3.93 | 4.16M |
| Aug 7, 2026 | $3.91 | $4.15 | $3.854 | $4.11 | 5.05M |
| Aug 6, 2026 | $3.815 | $3.93 | $3.69 | $3.89 | 9.31M |
| Aug 5, 2026 | $3.925 | $4.14 | $3.90 | $4.10 | 6.83M |
| Aug 4, 2026 | $3.82 | $4.00 | $3.78 | $3.96 | 5.12M |
| Aug 3, 2026 | $3.96 | $3.96 | $3.78 | $3.80 | 5.28M |
| Jul 31, 2026 | $4.09 | $4.1414 | $3.85 | $3.91 | 5.4M |
| Jul 30, 2026 | $3.90 | $4.12 | $3.88 | $4.11 | 4.14M |
| Jul 29, 2026 | $3.90 | $3.955 | $3.82 | $3.85 | 3.59M |
| Jul 28, 2026 | $3.98 | $4.00 | $3.8414 | $3.91 | 3.66M |
| Jul 27, 2026 | $4.21 | $4.235 | $3.95 | $3.95 | 5.33M |
| Jul 24, 2026 | $4.06 | $4.23 | $3.98 | $4.13 | 9.44M |
| Jul 23, 2026 | $3.73 | $3.91 | $3.7101 | $3.89 | 2.94M |
| Jul 22, 2026 | $4.06 | $4.07 | $3.805 | $3.84 | 5.54M |
Latest MNKD news
The latest Smart Investors Daily articles mentioning MNKD.
Stock researchCompany · Earnings
Loading stock research…